Reparixin (Repertaxin)
99%
- Product Code: 102281
Alias:
(R)-2-(4-isobutylphenyl)-N-(methylsulfonyl)propionamide
CAS:
266359-83-5
| Molecular Weight: | 283.39 g./mol | Molecular Formula: | C₁₄H₂₁NO₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Reparixin is primarily used in medical research and clinical settings for its anti-inflammatory properties. It functions as an inhibitor of CXCR1 and CXCR2 chemokine receptors, which play a significant role in neutrophil activation and migration. This makes it a potential therapeutic agent in conditions where inflammation and immune response need to be controlled, such as in acute respiratory distress syndrome (ARDS), sepsis, and ischemia-reperfusion injury. Additionally, it has been investigated for its role in reducing complications in organ transplantation by minimizing inflammatory damage. Reparixin is also being explored in cancer research to inhibit tumor-associated inflammation and metastasis. Its ability to modulate immune responses highlights its broad applicability in various inflammatory and immune-related disorders.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Yellow Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿1,130.00 |
+
-
|
| 0.005 | 10-20 days | ฿4,030.00 |
+
-
|
| 0.025 | 10-20 days | ฿13,530.00 |
+
-
|
Reparixin (Repertaxin)
Reparixin is primarily used in medical research and clinical settings for its anti-inflammatory properties. It functions as an inhibitor of CXCR1 and CXCR2 chemokine receptors, which play a significant role in neutrophil activation and migration. This makes it a potential therapeutic agent in conditions where inflammation and immune response need to be controlled, such as in acute respiratory distress syndrome (ARDS), sepsis, and ischemia-reperfusion injury. Additionally, it has been investigated for its role in reducing complications in organ transplantation by minimizing inflammatory damage. Reparixin is also being explored in cancer research to inhibit tumor-associated inflammation and metastasis. Its ability to modulate immune responses highlights its broad applicability in various inflammatory and immune-related disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :